Teva Pharmaceuticals USA, Inc. recalls Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (
Recalled March 20, 2013 · FDA recall D-193-2013 · Teva Pharmaceuticals USA
Hazard
Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle. · FDA Class II
Units
3,913 bottles
Sold at
Nationwide
Description
Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.
Product
Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.
Manufacturer(s)
Teva Pharmaceuticals USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →